One team of reps joined forces to make a difference.
If you have a product on a physician's top 20 list, you know how habit dictates prescribing practices. If you are trying to get a product on that list, you probably have an even deeper appreciation for the exclusivity of this phenomenon. Many physicians develop their prescribing habits during residency, which they may learn from their mentors and colleagues, and they continue the same practices as they move into their reserve specialties.
Primary care physicians quickly learn to identify the most common and routine complaints and develop a mental "reference guide" to treatment. Each positive outcome serves to reinforce the choices the physicians have made, creating a vicious circle and seemingly impenetrable barrier for pharmaceutical representatives.
Several years ago, Janssen Pharmaceutica's Philadelphia district launched a new product and received overwhelming support from physicians in the area. Market share quickly soared and success stories from doctors flooded in.
But about two years after the product entered the market, it appeared that Philadelphia-area physicians were not putting their enthusiasm into practice. Reps weren't hearing specific resistance about the product, but growth slowed.
Local reps met to brainstorm on how they could "relaunch" the product with their doctors and regain the initial enthusiasm and commitment. They needed to identify the real issues and find ways to successfully overcome them. Their unanimous conclusion, based on honest feedback from doctors, was habit. Old habits were holding doctors back from approaching treatment in a different way, although they often agreed that the product offered many benefits to their patients.
The question, therefore, was how to break doctors' old habits and create new ones that were just as powerful? The solution? A 21-day challenge.
Because 80% of sales came from only 20% of the doctors on whom reps were calling, each district rep chose one or two of his or her most influential doctors and focused exclusively on creating a new habit in those doctors.
First, the office staffs had to be informed. The reps explained that the doctors' support was very crucial and that they'd like "permission" to try to change the doctors' habits. The doctors were also informed from the onset. The reps explained their goals and intentions and requested the physicians' permission to try to change their habits. Most doctors were curious and looked forward to the challenge. Of course, the reps had to know their customers; not all offices would have responded favorably.
The 21 days were laid out on a calendar and each day had a specific focus with a targeted message. Because it was not geographically feasible for a rep to physically visit the office each day, the Philadelphia team pooled their resources and designed creative mailings, faxes and drop-offs so that the office would receive a reminder of the product each and every day for 21 straight days. The district came up with fun riddles, poems, candy, toys - inexpensive but powerful messages to keep the product in the doctors' minds each day. Messages centered around product effectiveness, safety, cost-savings and managed care benefits for patients and doctors.
In the past, individual reps had attempted similar ideas in their territories (some for five days in a row) and reported very positive feedback, but it was difficult to handle all the responsibility alone. What made the challenge a success was teamwork.
One rep left daily voice mail messages for participating district reps to remind them of which day of the challenge it was, what the goals of the day were and what marketing phrase the doctor's offices would hear that day. Another rep was responsible for mailing letters, another was in charge of faxing and another would send the toys or candy. The synergism made the 21-day challenge a unique and fun way to target key physicians and increase sales.
Response from the staff was also terrific. They looked forward to what would come each day. The doctors admired the drive and determination of the reps and they seemed flattered to have been singled out as the "most important." They also appreciated the staff involvement.
Overall, the challenge enhanced rapport with the doctors and the staff and helped reps gain future access to tough-to-see physicians. Although it was fun for everyone, it also served professional goals. Follow-up has been critical to avoid allowing doctors to slip back into their old habits. And because the challenge required relatively little effort to gain great results, and the Philadelphia team and other Janssen district sales forces plan to challenge more offices in the future! PR
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.